Oaktree Acquisition Corp. III Life Sciences (OACCU) Total Liabilities (2024 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Total Liabilities came in at $8.6 million in Q1 2026, up 7.0% YoY from $8.1 million in Q1 2025, and up 3.9% on a QoQ basis from $8.3 million in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Total Liabilities (2024 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 3 years of Total Liabilities data on file, last reported at $8.6 million in Q1 2026.
- Quarterly Total Liabilities rose 7.0% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 7.0% YoY) and the FY2025 annual result came in at $8.3 million, up 7.39% from the prior year.
- Total Liabilities grew to $8.6 million in Q1 2026, from $8.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $8.6 million in Q1 2026 to a low of $7.7 million in Q4 2024.
- A 3-year average of $8.2 million and a median of $8.2 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2025 — Total Liabilities rose 7.39% — and 2026, when it grew 7.0%.
- Tracing OACCU's Total Liabilities over 3 years: stood at $7.7 million in 2024, then increased by 7.39% to $8.3 million in 2025, then grew by 3.9% to $8.6 million in 2026.
- The last three Total Liabilities figures came in at $8.6 million (Q1 2026), $8.3 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.75 Mn |
| Mar 31, 2026 | 8.64 Mn |
| Dec 31, 2025 | 8.32 Mn |
| Sep 30, 2025 | 8.25 Mn |
| Jun 30, 2025 | 8.14 Mn |
| Mar 31, 2025 | 8.08 Mn |
| Dec 31, 2024 | 7.75 Mn |